Drug intelligence / Profile preview

Reginmune

Development stage
Unknown
Lead developer
Biogetica
Modality
Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Oral
01

Overview

Reginmune is a multi-ingredient dietary supplement and nutraceutical product formulated as a capsule containing a complex blend of phytochemicals, amino acids, vitamins, minerals, and a biological polymer. Its key components include herbal extracts such as **Echinacea** and **Cat's Claw** (*Uncaria tomentosa*), essential minerals like **Zinc**, **Copper**, and **Magnesium**, vitamins (specifically food-derived **Vitamin C**), and amino acids including **L-lysine**, **L-glutamine**, **L-arginine**, and **L-isoleucine**. The formulation also incorporates **Aloe vera** polysaccharides and **Sodium hyaluronate** within a cellular matrix. Reginmune is designed to act as an immunomodulator and antiviral agent, aiming to boost immune cell activity (such as T-cells and Natural Killer cells) and regulate cytokine production (e.g., TNF-alpha and IL-6). It has been clinically evaluated, often in combination with the polyherbal formulation Immunofree, for the treatment of mild to moderate COVID-19 to reduce symptoms and viral load.

Brand names
Reginmune
Other names
Reginmune Capsule
02

Targets

IL-6 (Interleukin 6)IL10 (Interleukin-10)IFN-α (Interferon alpha-7)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on Reginmune.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reginmune.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call